ICICI Prudential Nifty Pharma Index Fund - Direct Plan - Growth

Q: How much expense ratio is charged by ICICI Prudential Nifty Pharma Index Fund - Direct Plan - Growth?

The expense ratio for ICICI Prudential Nifty Pharma Index Fund - Direct Plan - Growth, or any other mutual fund, is the yearly fee you pay for managing your investments. As of 13 May 2025, the expense ratio charged by ICICI Prudential Nifty Pharma Index Fund - Direct Plan - Growth is typically around undefined %. This fee covers fund management, administrative, and other operational costs. It is relatively low compared to actively managed funds, reflecting its direct growth option.

Q: What is the AUM of ICICI Prudential Nifty Pharma Index Fund - Direct Plan - Growth?

As of 13 May 2025, the Assets Under Management (AUM) of ICICI Prudential Nifty Pharma Index Fund - Direct Plan - Growth is approximately ₹83.2502 crore. The AUM can fluctuate based on market conditions and investor activity. It indicates the total value of assets managed by the fund.

Q: What is the NAV of ICICI Prudential Nifty Pharma Index Fund - Direct Plan - Growth?

The Net Asset Value (NAV) of ICICI Prudential Nifty Pharma Index Fund - Direct Plan - Growth is updated daily and reflects the per-unit value of the fund's assets. As of 13 May 2025 , the NAV is around undefined per unit, but this value might change based on market performance and fund holdings.

Q: What is the PE and PB ratio of ICICI Prudential Nifty Pharma Index Fund - Direct Plan - Growth?

The PE ratio for ICICI Prudential Nifty Pharma Index Fund - Direct Plan - Growth is 39.64 and the PB ratio is 6.34. The PE ratio is calculated by dividing the market price by the earnings per share, whereas the PB ratio is calculated by dividing the stock price by the book value per share.

Q: What is the exit load of ICICI Prudential Nifty Pharma Index Fund - Direct Plan - Growth?

The exit load for ICICI Prudential Nifty Pharma Index Fund - Direct Plan - Growth is undefined% if units are redeemed within 30 days from the date of investment. After this period, no exit load is applicable. This fee is charged to discourage short-term trading and ensure long-term investment.

Other

NAV

₹ 16.48

CAGR (3 Years)

AUM (Cr)

₹ 83.25

Risk

Very High Risk

About ICICI Prudential Nifty Pharma Index Fund - Direct Plan - Growth

The objective of the Scheme is to invest in companies whose securities are included in Nifty Pharma Index and subject to tracking errors, to endeavor to achieve the returns of the above index. This would be done by investing in all the stocks comprising the Nifty Pharma Index in the same weightage t